Characterization of blood borne microparticles as markers of premature coronary calcification in newly menopausal women

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 295, Issue 3, 2008, Pages

  Jayachandran, Muthuvel ^a,b   Litwiller, Robert D ^a   Owen, Whyte G ^a   Heit, John A ^a,b   Behrenbeck, Thomas ^b   Mulvagh, Sharon L ^b   Araoz, Philip A ^b   Budoff, Matthew J ^c   Harman, S Mitchell ^d   Miller, Virginia M ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b Mayo Clinic   (United States)

^c HARBOR UCLA MEDICAL CENTER   (United States)

^d Kronos Longevity Research Institute   (United States)

Author keywords

Phosphatidylserine; Procoagulant activity; Thrombosis

Indexed keywords

C REACTIVE PROTEIN; ESTROGEN; LIPID; PHOSPHATIDYLSERINE; PROCOAGULANT; THROMBIN; BIOLOGICAL MARKER; CALCIUM; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; LIPOCORTIN 5; NANOPARTICLE;

ADULT; ARTERY CALCIFICATION; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE COURSE; ENDOTHELIAL MICROPARTICLE; FEMALE; FLOW CYTOMETRY; HIGH RISK PATIENT; HUMAN; LIPID BLOOD LEVEL; MEMBRANE MICROPARTICLE; MENOPAUSE; MONOCYTE; PHENOTYPE; PLATELET MICROPARTICLE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; BIOSYNTHESIS; BLOOD; BLOOD ANALYSIS; BLOOD CELL COUNT; BLOOD CLOTTING; CALCINOSIS; CORONARY BLOOD VESSEL; CROSS-SECTIONAL STUDY; ENDOTHELIUM CELL; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; THROMBOCYTE;

ADULT; ANNEXIN A5; BIOLOGICAL MARKERS; BLOOD CELL COUNT; BLOOD CHEMICAL ANALYSIS; BLOOD COAGULATION; BLOOD PLATELETS; CALCINOSIS; CALCIUM; CORONARY VESSELS; CROSS-SECTIONAL STUDIES; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; INDICATORS AND REAGENTS; MENOPAUSE; MIDDLE AGED; NANOPARTICLES; THROMBIN;

EID: 54049113531     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00193.2008     Document Type: Article

References (45)

1. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15: 827-832, 1990.
2. Amabile N, Guerin AP, Leroyer A, Mallat Z, Nguyen C, Boddaert J, London GM, Tedgui A, Boulanger CM. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol 16: 3381-3388, 2005.
3. Amabile N, Heiss C, Real WM, Minasi P, McGlothlin D, Rame EJ, Grossman W, De Marco T, Yeghiazarians Y. Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension. Am J Respir Crit Care Med 177: 1268-1275, 2008.
4. Andersson T, Flockhart DA, Goldstein DB, Huang SM, Kroetz DL, Milos PM, Ratain MJ, Thummel K. Drug-metabolizing enzymes: evidence for clinical utility of pharmacogenomic tests. Clin Pharmacol Ther 78: 559-581, 2005.
5. Bairey Merz CN, Shaw LJ, Reis SE, Bittner V, Kelsey SF, Olson M, Johnson BD, Pepine CJ, Mankad S, Sharaf BL, Rogers WJ, Pohost GM, Lerman A, Quyyumi AA, Sopko G. Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol 47: S21-S29, 2006.
6. Berckmans RJ, Neiuwland R, Boing AN, Romijn FP, Hack CE, Sturk A. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 85: 639-646, 2001.
7. Bobryshev YV, Lord RS, Tran D. Chlamydia pneumoniae in foci of "early" calcification of the tunica media in arteriosclerotic arteries: an incidental presence? Am J Physiol Heart Circ Physiol 290: H1510-H1519, 2006.
8. Boulanger CM, Amabile N, Tedgui A. Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease. Hypertension 48: 180-186, 2006.
9. Boulanger CM, Scoazec A, Ebrahimian T, Henry P, Mathieu E, Tedgui A, Mallat Z. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 104: 2649-2652, 2001.
10. Bulut D, Maier K, Bulut-Streich N, Borgel J, Hanefeld C, Mugge A. Circulating endothelial microparticles correlate inversely with endothelial function in patients with ischemic left ventricular dysfunction. J Card Fail 14: 336-340, 2008.
11. Chironi G, Simon A, Hugel B, Del Pino M, Gariepy J, Freyssinet JM, Tedgui A. Circulating leukocyte-derived microparticles predict subclinical atherosclerosis burden in asymptomatic subjects. Arterioscler Thromb Vasc Biol 26: 2775-2780, 2006.
12. Corti R, Hutter R, Badimon JJ, Fuster V. Evolving concepts in the triad of atherosclerosis, inflammation and thrombosis. J Thromb Thrombolysis 17: 35-44, 2004.
13. Desai MY, Nasir K, Braunstein JB, Rumberger JA, Post WS, Budoff MJ, Blumenthal RS. Underlying risk factors incrementally add to the standard risk estimate in detecting subclinical atherosclerosis in low- and intermediate-risk middle-aged asymptomatic individuals. Am Heart J 148: 871-877, 2004.
14. Distler JH, Huber LC, Gay S, Distler O, Pisetsky DS. Microparticles as mediators of cellular cross-talk in inflammatory disease. Autoimmunity 39: 683-690, 2006.
15. Doherty TM, Fitzpatrick LA, Shaheen A, Rajavashisth TB, Detrano RC. Genetic determinants of arterial calcification associated with atherosclerosis. Mayo Clin Proc 79: 197-210, 2004.
16. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285: 2486-2497, 2001.
17. Fitzpatrick LA, Turner RT, Ritman ER. Endochondral bone formation in the heart: a possible mechanism of coronary calcification. Endocrinology 144: 2214-2219, 2003.
18. Harman SM, Brinton EA, Cedars M, Lobo R, Manson JE, Merriam GR, Miller VM, Naftolin F, Santoro N. KEEPS: The Kronos Early Estrogen Prevention Study. Climacteric 8: 3-12, 2005.
19. Hartman A, Saeed M, Bing RJ. Release of endothelium-derived relaxing factor from freshly harvested porcine endothelial cells. Circ Res 61: 548-554, 1987.
20. Healy AM, Pickard MD, Pradhan AD, Wang Y, Chen Z, Croce K, Sakuma M, Shi C, Zago AC, Garasic J, Damokosh AI, Dowie TL, Poisson L, Lillie J, Libby P, Ridker P, Simon DI. Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events. Circulation 113: 2278-2284, 2006.
21. Horstman LL, Jy W, Jimenez JJ, Ahn YS. Endothelial microparticles as markers of endothelial dysfunction. Front Biosci 9: 1118-1135, 2004.
22. Hsu HH, Tawfik O, Sun F. Mechanisms of calcification by vesicles isolated from atherosclerotic rabbit aortas. Biochim Biophys Acta 1563: 18-22, 2002.
23. Jayachandran M, Brunn GJ, Karnicki K, Miller RS, Owen WG, Miller VM. In vivo effects of lipopolysaccharide and TLR4 on platelet production and activity: implications for thrombotic risk. J Appl Physiol 102: 429-433, 2007.
24. Jimenez JJ, Jy W, Mauro LM, Soderland C, Horstman LL, Ahn YS. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res 109: 175-180, 2003.
25. Lakoski SG, Cushman M, Blumenthal RS, Kronmal R, Arnett D, D'Agostino RB Jr, Detrano RC, Herrington DM. Implications of C-reactive protein or coronary artery calcium score as an adjunct to global risk assessment for primary prevention of CHD. Atherosclerosis 193: 401-407, 2007.
26. Lakoski SG, Greenland P, Wong ND, Schreiner PJ, Herrington DM, Kronmal RA, Liu K, Blumenthal RS. Coronary artery calcium scores and risk for cardiovascular events in women classified as "low risk" based on Framingham risk score: The Multi-Ethnic Study of Atherosclerosis (MESA). Arch Intern Med 167: 2437-2442, 2007.
27. Leroyer AS, Isobe H, Leseche G, Castier Y, Wassef M, Mallat Z, Binder BR, Tedgui A, Boulanger CM. Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. J Am Coll Cardiol 49: 772-777, 2007.
28. Libby P. Inflammation in atherosclerosis. Nature 420: 868-874, 2002.
29. Lynch SF, Ludlam CA. Plasma microparticles and vascular disorders. Br J Haematol 137: 36-48, 2007.
30. Manson J, Allison M, Rossouw JE, Carr J, Langer R, Hsia J, Kuller L, Cochrane B, Hunt J, Ludlam S, Pettinger M, Gass M, Margolis K, Nathan L, Ockene J, Prentice R, Robbins JR, Stefanick M. Estrogen therapy and coronary-artery calcification. N Engl J Med 356: 2591-2602, 2007.
31. McDowell EM, Trump BF. Histologic fixatives suitable for diagnostic light and electron microscopy. Arch Pathol Lab Med 100: 405-414, 1976.
32. Miller VM, Rodgers G, Charlesworth JA, Kirkland B, Severson SR, Rasmussen TE, Yagubyan M, Rodgers JC, Cockerill FR 3rd, Folk RL, Kumar V, Farell-Baril G, Lieske JC. Evidence of nanobacterial-like structures in human calcified arteries and cardiac valves. Am J Physiol Heart Circ Physiol 287: H1115-H1124, 2004.
33. Morel O, Toti F, Hugel B, Bakouboula B, Camoin-Jau L, Dignat-George F, Freyssinet JM. Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscler Thromb Vasc Biol 26: 2594-2604, 2006.
34. Morel O, Toti F, Hugel B, Freyssinet JM. Cellular microparticles: a disseminated storage pool of bioactive vascular effectors. Curr Opin Hematol 11: 156-164, 2004.
35. Mutin M, Dignat-George F, Sampol J. Immunologic phenotype of cultured endothelial cells: quantitative analysis of cell surface molecules. Tissue Antigens 50: 449-458, 1997.
36. Newman PJ. The biology of PECAM-1. J Clin Invest 99: 3-8, 1997.
37. - microparticles to endothelial progenitors as a novel marker of atherosclerosis in hypercholesterolemia. Arterioscler Thromb Vasc Biol 26: 2530-2535, 2006.
38. Pradhan AD, Manson JE, Rossouw JE, Siscovick DS, Mouton CP, Rifai N, Wallace RB, Jackson RD, Pettinger MB, Ridker PM. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease. Prospective analysis from the Women's Health Initiative Observational Study. JAMA 288: 980-987, 2002.
39. Ridker PM. C-reactive protein, inflammation, and cardiovascular disease: clinical update. Tex Heart Inst J 32: 384-386, 2005.
40. Ross R. Cell biology of atherosclerosis. Annu Rev Physiol 57: 791-804, 1995.
41. Shaw LJ, Bairey Merz CN, Pepine CJ, Reis SE, Vittner V, Kelsey SF, Olson M, Delia Johnson B, Mankad S, Sharaf BL, Rogers WJ, Wessel TR, Arant CB, Pohost GM, Lerman A, Quyyumi AA, Sopko G. Insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) Study. J Am Coll Cardiol 47: 4S-20S, 2006.
42. Tintut Y, Demer LL. Recent advances in multifactorial regulation of vascular calcification. Curr Opin Lipidol 12: 555-560, 2001.
43. VanWijk MJ, VanBavel E, Sturk A, Nieuwland R. Microparticles in cardiovascular diseases. Cardiovasc Res 59: 277-287, 2003.
44. + apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 26: 112-116, 2006.
45. Zwaal RF, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 89: 1121-1132, 1997.